A New Model to Predict Remission Status in AML Patients Based on Day 14 Bone Marrow Biopsy

Highlights • A new model for interpreting Day 14 bone marrow biopsy results in patients AML was developed. • This model incorporates both clinical had laboratory parameters. • This new model provides better accuracy for predicting the likelihood of achieving remission.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia research 2016-07, Vol.46, p.69-73
Hauptverfasser:	Norkin, Maxim, Chang, Myron, An, Qi, Leather, Helen, Katragadda, Lakshmikanth, Li, Ying, Moreb, Jan S, May, W. Stratford, Brown, Randy A, Hsu, Jack W, Hiemenz, John W, Wingard, John R, Cogle, Christopher R
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged AML Biopsy Bone Marrow - pathology Day 14 bone marrow biopsy Granulocyte Precursor Cells - pathology Hematology, Oncology and Palliative Medicine Humans Leukemia, Myeloid, Acute - pathology Middle Aged Models, Theoretical Predictive Value of Tests Prognosis Rellapse Remission Remission Induction Response to therapy Retrospective Studies Time Factors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • A new model for interpreting Day 14 bone marrow biopsy results in patients AML was developed. • This model incorporates both clinical had laboratory parameters. • This new model provides better accuracy for predicting the likelihood of achieving remission.
ISSN:	0145-2126 1873-5835
DOI:	10.1016/j.leukres.2016.04.013